Physician profile
Warren Roland Carter
NPI 1306662267
$3,142.80
in general payments reported to CMS, 2019-2025
15 companies · $3,143 in 2025
The $3,143 reported for 2025 was more than what 94% of Psychiatric/Mental Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $244).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,134 · Education: $9.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,133.71 |
| Education | $9.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $748.44 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $455.97 | 2025 | Austedo Xr, Uzedy |
| Alkermes, INC. | $321.15 | 2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $310.45 | 2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $275.37 | 2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $240.13 | 2025 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $173.20 | 2025 | Cobenfy |
| Abbvie INC. | $168.36 | 2025 | |
| Lundbeck LLC | $122.54 | 2025 | Rexulti |
| Bausch Health US, LLC | $84.42 | 2025 | Aplenzin, Wellbutrin |
| Janssen Pharmaceuticals, INC | $56.18 | 2025 | Spravato |
| Noven Therapeutics, LLC | $54.91 | 2025 | Xelstrym |
| Tris Pharma INC | $51.82 | 2025 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $45.67 | 2025 | Auvelity |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $34.19 | 2025 | Rejoyn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.